Pharmaceutical and Biotechnology Royalty Rates Report 2024: Essential Benchmark Data for Dealmakers – Royalty Rates, Deal Financials, Contract Documents, Royalty Rate Trends

DUBLIN, March 13, 2024 /PRNewswire/ — The “Royalty Rates in Pharmaceutical and Biotechnology Deals” report has been added to ResearchAndMarkets.com’s offering.

Royalty Rates in Pharmaceutical and Biotechnology Deals is your one-stop source for providing real-deal information on hundreds of transactions, including the technology licensed, royalty rates, license fees, upfront and milestone payments.

This report provides details of the latest partnering deals which disclose a royalty rate, announced in the pharmaceutical, biotechnology and diagnostic sectors. The report provides details of partnering deals disclosing royalty rates from 2010 to 2024.

The report provides an overview of how and why companies enter partnering deals where a royalty is payable upon commercialization of the compound or technology.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of all partnering deals announced since 2010 where a quantitative royalty rate has been disclosed, as recorded in the Current Agreements deals and alliances database. Each deal record and royalty disclosure is available in further detail via a link to online copy of the deal including actual contract document, where available, as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of royalty rate trends in pharma and biotech since 2010. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in royalty rates in the pharma and biotech sectors since 2010.

Chapter 3 provides a more detailed insight into the structure of a royalty rate clause and how it fits with the other financial terms of the partnering deal.

Chapter 4 provides an insight into companies active in disclosing royalty rates as well as those deals attracting the highest royalty rates.

Chapter 5 provides comprehensive and detailed access to deals which disclose a royalty rate since 2010 where a contract document is available. Contract documents provide an in-depth insight into the actual deal terms agreed between the parties with respect to the royalty rate.

In addition the report includes a comprehensive deal directory listing of all deals where a royalty rate has been disclosed announced since 2010. Each listing is organized as a directory by company A-Z, stage of development at signing, therapeutic area, and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.

The report also includes numerous table and figures that illustrate the trends in royalty rates in pharma and biotech deal making since 2010. In conclusion, this report provides everything a prospective dealmaker needs to know about royalty rates in the pharma and biotech sector.

Royalty Rates in Pharmaceutical and Biotechnology Deals provides the following benefits:

Understand royalty rate trends since 2010Analysis of the structure of royalty clauses with real life case studiesBrowse collaboration and licensing deals which reveal a royalty rateBenchmark analysis – identify market value of transactionsFinancials terms – upfront, milestone, royaltiesDirectory of deals by company A-Z, therapy focus and technology typeAccess contract documents – insights into deal structuresDue diligence – assess suitability of your proposed deal terms for partner companiesSave hundreds of hours of research time

Analyzing actual contract agreements allows assessment of the following:

What are the precise royalty rates granted?What is actually granted by the agreement to the partner company?What exclusivity is granted?What is the payment structure for the deal?How are sales and payments audited?What is the deal term?How are the key terms of the agreement defined?How are IPRs handled and owned?Who is responsible for commercialization?Who is responsible for development, supply, and manufacture?How is confidentiality and publication managed?How are disputes to be resolved?Under what conditions can the deal be terminated?What happens when there is a change of ownership?What sublicensing and subcontracting provisions have been agreed?Which boilerplate clauses does the company insist upon?Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?Which jurisdiction does the company insist upon for agreement law?

Key Topics Covered:

 Executive Summary

Chapter 1 – Introduction
1.1. What are royalties?
1.2. History of royalty rates
1.3. Royalties in pharmaceuticals and biotechnology
1.4. Royalties versus revenue share
1.5. Overview of the report

Chapter 2 – An overview of pharmaceutical and biotechnology royalty rates
2.1. Trends in royalty rates 2010 – 2024
2.2. How do revenue shares figure?
2.3. A review of recent literature
2.4. Royalty rates in the future

Chapter 3 – The royalty clause in pharmaceutical and biotechnology deals
3.1. Partnering agreement structure
3.2. Structure of a typical royalty clause
3.3. Example royalty clauses
3.3.1. Case study 1
3.3.2. Case study 2
3.3.3. Case study 3
3.3.4. Case study 4

Chapter 4 – Companies actively disclosing royalty rates
4.1. Most active companies in disclosing royalty rates

Chapter 5 – Royalty rate contract directory
Explore royalty rates within the deal contract document to gain greater insight

Deal directory
Deal Directory – Royalty rates in deals – by company A-Z
Deal Directory – Royalty rates in deals – by therapy area
Deal Directory – Royalty rates in deals – by stage of development at signing
Deal Directory – Royalty rates in deals – by technology type

Royalty rate references
Example royalty rate deal contract document
List of Figures
Figure 1: Trends in pharma and biotech royalty rates, 2010 – 2024
Figure 2: Components of the partnering deal structure
Figure 3: Components of the partnering royalty clause
Figure 4: Most active companies disclosing royalty rate 2010 – 2024
Figure 5: Licensing agreement for rhAAT – rEVO Biologics, LFB Biotechnologies

Companies Mentioned

2seventy bio3a-diagnostics3D Medicines4SC23andMeAbbott LaboratoriesAbbvieAbeona TherapeuticsAblynxAbraxis BioScienceABVC BioPharmaACADIA PharmaceuticalsAcceleron PharmaAcelrx PharmaceuticalsAcer TherapeuticsAcerusAcrotech BiopharmaActavis (acquired by Watson)Active BiomaterialsAcura PharmaceuticalsAdamis PharmaceuticalsAdaptimmuneADC TherapeuticsAdeona PharmaceuticalsAdial PharmaceuticalsAditx TherapeuticsAdlai NortyeAduro BioTechAdvanced Dosage FormsAdvanz PharmaAdvaxisAdvirnaAegerion PharmaceuticalAeglea BioTherapeuticsAerie PharmaceuticalsAEterna ZentarisAexon LabsAffimed TherapeuticsAfritex Medical ProductsAFT PharmaceuticalsAgenus BioAgios PharmaceuticalsAguettantAiBtl BioPharmaAIT TherapeuticsAkcea TherapeuticsAkebia TherapeuticsAlbert Einstein College of MedicineAlchemiaAlder BiopharmaceuticalsAlectorAlexion PharmaceuticalsAlexza PharmaceuticalsAlfasigmaAlfa WassermannAllerganAllergan (name changed from Actavis)AlmirallAlnylam PharmaceuticalsAlora PharmaceuticalsAlpha BiopharmaAlternavidaAltman EnterprisesAltrazealTradingAltum PharmaceuticalsAlvogenAmarantus BioSciencesAmerican Type Culture Collection (ATCC)AmgenAmherst PharmaceuticalsAmorfix Life SciencesAmpio PharmaceuticalsAmryt PharmaAmylin PharmaceuticalsAmyrisAnaBiosAnaptysBioAnGes MGAngion BiomedicaAnnaMedAntares PharmaAntibe TherapeuticsAntigen ExpressApplied TherapeuticsApricus BiosciencesAquestive TherapeuticsAradigmAratana TherapeuticsArcellxArch PharmalabsArctic VisionArcturus TherapeuticsArcus BiosciencesArdelyxArena PharmaceuticalsArrowhead PharmaceuticalsArtiva BiotherapeuticsArvinasAscendis PharmaAscentage PharmaAshvattha TherapeuticsAssembly BiosciencesAstellas PharmaAstellas Pharma EuropeAsterias BiotherapeuticsAstraZenecaAthenexAtossa TherapeuticsAtrecaAudeo OncologyAugmentaAurigene Discovery TechnologiesAurinia PharmaceuticalsAuthentic Brands GroupAVEO OncologyAvita TherapeuticsAvivagenAxovant Gene TherapiesAxsome TherapeuticsAytu BioPharmaAzaya TherapeuticsAzure BiotechBaker Brothers InvestmentsBAKX TherapeuticsBaliopharmBASFBaxter InternationalBayer HealthcareBayer InnovationBaylor Research InstituteBeam TherapeuticsBeiGeneBeijing Defengrei BiotechnologyBelgian VolitionBellerophon TherapeuticsBenitec BiopharmaBesins HealthcareBeth Israel Deaconess Medical CenterBetterLife PharmaBharat BiotechBIND BiosciencesBioCorRxBioCryst PharmaceuticalsBioeq IPBiogenBioGene TechnologyBiohaven PharmaceuticalsBioInventBiolineRXBioMarin PharmaceuticalBioNovionBioNTechBioNxt SolutionsBiopharmexBiopharmXBioPortoBioprocess Capital VenturesBioProspectBiostem USBiotech InvestmentBiotechnology Value FundBioTime AcquisitionBiotonBiovailBioZone LaboratoriesBioZone PharmaceuticalsBlackstoneBluebird BioBlueprint MedicinesBMV MedicaBoehringer IngelheimBone TherapeuticsBraeburn PharmaceuticalsBrainStorm Cell TherapeuticsBreathtec BioMedicalBrickell BiotechBridgeBio PharmaBridge BiotherapeuticsBristol-Myers SquibbCaleco PharmaCalicoCan-Fite BioPharmaCancer Prevention PharmaceuticalsCannassure TherapeuticsCanniMed TherapeuticsCann Pharmaceutical AustraliaCanntab TherapeuticsCannus PartnersCantex PharmaceuticalsCara TherapeuticsCardigant MedicalCardium TherapeuticsCareFusionCarna BioSciencesCary PharmaceuticalsCASI PharmaceuticalsCastle Creek BiosciencesCatalentCB2 TherapeuticsCeldara MedicalCelgeneCell Cure NeurosciencesCellveraCel SciCelyadCereal IngredientsCerebain BiotechCerusCGA 369cGreenChi-MedChiesi FarmaceuticiChimerixChong Kun DangChongqing Jingdong PharmaceuticalCimtechCipher PharmaceuticalsCiplaCircassiaClal BiotechClalit Health ServicesClearmind MedicineClearside BiomedicalClemson UniversityCleveland BioLabsClinigenCMICCNS PharmaceuticalsCocrystal PharmaCoeptis PharmaceuticalsCohBarCohen-McNiece FoundationCoherus BiosciencesColby PharmaceuticalsCollegium PharmaceuticalsColumbia LaboratoriesColumbia UniversityCommon SenseConatus PharmaceuticalsConcileConsilient HealthContraFectCoronado BiosciencesCosmofixCosmo PharmaceuticalsCoya TherapeuticsCRISPR TherapeuticsCrossjectCrucellCSLCTI BioPharmaCTT PharmaceuticalCullinan OncologyCumberland PharmaceuticalsCures Within ReachCureTechCurisCurrax PharmaceuticalsCURx PharmaceuticalsCutanea Life SciencesCybinCymaBay TherapeuticsCypress BioscienceCytodynCytokineticsCytori TherapeuticsDaewoong PharmaceuticalDaiichi SankyoDana-Farber Cancer InstituteDance BiopharmDAS TherapeuticsDefiante FarmaceuticaDenali TherapeuticsDepoMedDerma SciencesDermavant SciencesDerminDianomi TherapeuticsDicerna PharmaceuticalsDNA Biomedical SolutionsDr. Falk PharmaDr. Reddy’s LaboratoriesDragonfly TherapeuticsDRI CapitalDrugs for Neglected Diseases InitiativeDS HealthcareDuke UniversityDyaxEagle PharmaceuticalsEagle Pharmaceuticals (US)Easton PharmaceuticalsEcho TherapeuticsEcology CoatingsEczacibasi PharmaceuticalsEddingpharmEgaletEisaiElenceeEli LillyElite PharmaceuticalsEmergent BioSolutionsEmory UniversityEnalare TherapeuticsEndocyteEndo PharmaceuticalsEnGeneICEnochian BiosciencesEntera BioEntest BioMedicalEnWaveEpizymeEpocalEsperion TherapeuticsEternity HealthcareEton PharmaceuticalsEureka GenomicsEUSA PharmaEvolvaEwopharmaExact SciencesExelixisExScientiaEyevanceFairview Health SystemFasTrack PharmaceuticalsFerozsons LaboratoriesFerring PharmaceuticalsFibrocell ScienceFoghorn TherapeuticsForest LaboratoriesFosun PharmaceuticalFox Chase Chemical Diversity CenterFresenius Kabi PharmaceuticalsFSD PharmaFusion PharmaceuticalsFusionVaxGalapagosGalmed PharmaceuticalsGE HealthcareGenentechGenerex BiotechnologyGenevant SciencesGenexineGenfitGenmabGentiumGenzymeGeronGilead SciencesGlaukosGlenmark Generics Inc USAGlenmark PharmaceuticalsGoldfinch BioGovernment of IsraelGPCR TherapeuticsGravocoreGrifolsGSKGT BiopharmaHai Kang LifeHail First PharmaHainan Sihuan PharmaceuticalHalo LabsHalozyme TherapeuticsHansen MedicalHealth CanadaHealthcare Royalty PartnersHealth DiscoveryHeartseedHeat BiologicsHefei Life ScienceHefei Tianhui Incubation of TechnologiesHekaBioHelsinn TherapeuticsHemoCleanseHemogenyxHemPupHenlius BiotechHetero LabsHIBM Research GroupHikma PharmaceuticalsHoffmann La RocheHollister BiosciencesHookipa PharmaHorizon Pharma IncHuadong MedicineHyperGenomicsI-mabIcahn School of Medicine at Mount SinaiIce + JamIconovoIDC-GP PharmIDEAYA BiosciencesIdera PharmaceuticalsIdorsiaIdun PharmaceuticalsIGM BiosciencesiMetabolic BiopharmaImmugenyxImmunicImmunityBioImmunomedicsImmunomic TherapeuticsImmunovative TherapiesImmViraImpax LaboratoriesImprimis PharmaceuticalsIn4DermiNAPIncannex HealthcareIncuronIncyteIndiana UniversityInfinity PharmaceuticalsInflaRxInhibitor TherapeuticsInnate PharmaInnocollInnovate BiopharmaceuticalsInnovation PharmaceuticalsInnovent BiologicsInnovetInnovus PharmaceuticalsINO TherapeuticsInspiration BiopharmaceuticalsInstrumentation LaboratoryIntelGenxIntellia TherapeuticsIntelliCell BioSciencesIntellikineInternet Marketing ConsortiumIntrexonIntuitive SurgicalInvekraInverness Medical InnovationsIonis PharmaceuticalsIpsenIroko PharmaceuticalsIronwood PharmaceuticalsIsraeli National Authority for Technological InnovationItrom Pharmaceutical GroupIvantisJaguar HealthJanssen BiotechJanssen PharmaceuticalsJazz PharmaceuticalsJFC TechnologiesJiangsu AlphamabJiangsu Lianhuan PharmaceuticalsJiangsu NHWA PharmaceuticalJi Xing PharmaceuticalsJohn Morley FoodsJoincare PharmaceuticalJourney MedicalJubilant Life SciencesJumpcan PharmaceuticalJuniper PharmaceuticalsJunshi BiosciencesJupiter WellnessJuventas TherapeuticsK2MKadmon PharmaceuticalsKaken PharmaceuticalKalbe Genexine BiologicsKaloBios PharmaceuticalsKarveer MeditechKemPharmKensey NashKieran MurphyKinetic ConceptsKiniksa PharmaceuticalsKintorKiromic BiopharmaKite PharmaKitov PharmaKlariaKlinge BiopharmaKnighton FoodsKnight TherapeuticsKodiak SciencesKowaKraig Biocraft LaboratoriesKVK-TechKwang Dong PharmaceuticalKymera TherapeuticsKyowa Hakko KirinKyverna TherapeuticsL1 SystemsLaboratories AcbelLantheus HoldingLaunch TherapeuticsLee Moffitt Cancer CenterLegend BiotechLegoChem BiosciencesLevel BrandsLFB BiotechnologiesLifestyle Delivery SystemsLigand PharmaceuticalsLineage Cell TherapeuticsLink HealthLipidorLipocineLixte BiotechnologyLorna Linda UniversityLotus PharmaceuticalsLoxo OncologyLubrizolLumenisLundbeckLung TherapeuticsMabCureMacrogenicsMagenta TherapeuticsMainPointeMallinckrodt PharmaceuticalsMarvanalMarv EnterprisesMassachusetts General HospitalMatrix BiomedMayne PharmaMcComb FoundationMcEwen Centre for Regenerative MedicineMedaMedicaMedica AvanteMedical Technologies Innovation AsiaMedice Arzneimittel PutterMedicines Patent Pool FoundationMedicoxMediGeneMedigusMedImmuneMedison PharmaMedivationMedivirMedovexMEI PharmaMelmedMemory DxMercer UniversityMerck and CoMerck KGaAMerck SeronoMerusMethodist Hospital HoustonMicrometMikah PharmaMillenniumMimi’s RockMindset PharmaMinistry of HealthLabor and WelfareMiNK TherapeuticsMiraculinsMiralogxMira PharmaceuticalsMiromatrix MedicalMitsubishi Tanabe PharmaModernaModis TherapeuticsMoleculin BiotechMologenMomenta PharmaceuticalsMonash UniversityMonopar TherapeuticsMorgan StanleyMorphoSysMount Sinai Health SystemMultiCell ImmunotherapeuticsMunich Leukemia LaboratoryMylan LaboratoriesMylan PharmaceuticalsMyovant SciencesNanoVibronixNanoViricidesNantCellNantKwestNantong Jinghua PharmaceuticalNantWorksNapo PharmaceuticalsNatac BiotechNatco PharmaceuticalsNational Green BiomedNektar TherapeuticsNeogenomicsNeotopeNephrogenexNephrosNestle Health ScienceNeuraxpharmNeurocrine BiosciencesNeuroRxNeuroSigmaNeuroVive PharmaceuticalNeuroVive Pharmaceutical AsiaNewLeaf BrandsNewsoara BiopharmaNew York UniversityNexMedNextCureNextleaf SolutionsNexvetNGM BiopharmaceuticalsNicoxNkarta TherapeuticsNLS PharmaceuticsNordic BioscienceNorgineNorthStar Medical RadioisotopesNotable LabsNovadaq TechnologiesNovaDel PharmaNovanNovan TherapeuticsNovartisNovartis Vaccines and DiagnosticsNovocureNovo NordiskNovus BiologicalsNRx PharmaceuticalsNucorionNumabNunzi PharmaceuticalNurix TherapeuticsNutech MedicalNutraOriginNXTGENNymox PharmaceuticalOberland CapitalOcugenOculus Innovative SciencesOcumension TherapeuticsOmerosOncologieOncolytics BiotechOncoMed PharmaceuticalsOnconova TherapeuticsOnegevityOne Way Liver Genomics (OWL)ONK TherapeuticsOno PharmaceuticalOnxeoOnyx PharmaceuticalsOpexa TherapeuticsOptheaOptiBiotixOptiNoseOragenicsOramed PharmaceuticalsOrexigen TherapeuticsOrganovoOrgenesisOrionOrox PharmaceuticalsOrthoCyteOtsukaOvaMedOvid TherapeuticsOxford BioMedicaOxis BiotechOxygen BiotherapeuticsOxySure SystemsOyster Point PharmaPan-Provincial Vaccine EnterpriseParnell PharmaceuticalsPar PharmaceuticalPDL BioPharmaPDS BiotechnologyPenwest PharmaceuticalsPernix TherapeuticsPerugia UniversityPfenexPfizerPharmacyclicsPharmaCyte BiotechPharmaMarPharmaNovaPharmastripPhilogenPhosphagenicsPhotocure ASAPhusion LaboratoiesPhyto NutricarePipex PharmaceuticalsPlandai BiotechnologyPluristem TherapeuticsPOINT BiopharmaPortola PharmaceuticalsPoseida TherapeuticsPozenPreMDPremier BiomedicalProfessional Compounding Centers of AmericaProgenics PharmaceuticalsPrometic Life SciencesProQR TherapeuticsProsidionProtagonist TherapeuticsProtalix BioTherapeuticsProteonomixProthenaProtoKinetixPulmatrixPuma BiotechnologyQED TherapeuticsQRxPharmaQuick Med TechnologiesQuigley CorporationQuoin PharmaceuticalsRayner SurgicalReata PharmaceuticalsRecordatiRecro PharmaRedHill BiopharmaReedy Creek InvestmentsRegenaStemRegeneron PharmaceuticalsRegenxbioRegnumRelay TherapeuticsRelief TherapeuticsRelmada TherapeuticsRenalytixAIReNeuronRepare TherapeuticsReplicel Life SciencesRepligenReprise BiomedicalResarci TherapeuticsRetrophinrEVO BiologicsRevolution MedicinesRigel PharmaceuticalsRNL BioRocheRockefeller UniversityRoivant SciencesRoyalty PharmaRST Biomedikal SanayiRuthigenRXi PharmaceuticalsS2 TherapeuticsSACCOSagard Healthcare Royalty PartnersSage TherapeuticsSalix PharmaceuticalsSam AmerSanara MedTechSandozSanofiSanofi-AventisSanofi-PasteurSanpellegrino CosmeticsSantarusSanten PharmaceuticalSanuwave HealthSA PathologySapientia PharmaceuticalsSarepta TherapeuticsSchrodingerScopus BioPharmaSeagenSeattle GeneticsSeelos TherapeuticsSekris BiomedicalSenetekSenior ParadiseSensory CloudSeqirusSeres TherapeuticsSermonix PharmaceuticalSesen BioSevenScore PharmaceuticalsShanghai Pharmaceuticals HoldingsSheba Medical CenterShenzhen BioScien PharmaceuticalsShield TherapeuticsShionogiShire PharmaceuticalsShore TherapeuticsSiemens Healthcare DiagnosticsSigma-TauSinclair PharmaceuticalsSinobiopharmaSinopharmSio Gene TherapiesSkinveraSkyline DiagnosticsSolarvest BioEnergySolianceSoligenixSonoma BioTherapeuticsSorrento TherapeuticsSpectraneticsSpencer PharmaceuticalSpinal USASt. Jude Children’s Research HospitalSTADA ArzneimittelStaidson (Beijing) BioPharmaceuticalsStanford UniversityStealth BioTherapeuticsStellar BiotechnologiesSt Jude MedicalStoke TherapeuticsStrongbridge BiopharmaSucampo AGSUDA PharmaceuticalsSumitomo Dainippon PharmaSunesis PharmaceuticalsSunovion PharmaceuticalsSun PharmaceuticalSuperNova DiagnosticsSutro BiopharmaSwedish Orphan BiovitrumSymBio PharmaceuticalsSymbollonSyndax PharmaceuticalsSynergy StripsSyntopixTactical ReliefTaibaTaiGen BiotechnologyTaihoTakeda PharmaceuticalTalaris TherapeuticsTango TherapeuticsTarget GroupTauriga SciencesTB AllianceTearLabTechnion Research and Development FoundationTeijinTelomir PharmaceuticalsTesaroTetra Bio-PharmaTetraLogic PharmaceuticalsTeva Pharmaceutical IndustriesTexas A&M UniversityTexas Heart InstituteTFF PharmaceuticalsTG TherapeuticsTherakineTherapeuticsMDTheravanceTheravance BiopharmaThe Regents of the University of CaliforniaThorne ResearchThreshold PharmaceuticalsTiGenixTilrayTitterington Veterinary ServicesTiziana Life SciencesTocagenTONIX PharmaceuticalsTorii PharmaceuticalTRACON PharmaceuticalsTramorganTransgeneTravere TherapeuticsTrellis BioscienceTrevenaTrimedyneTrimerisTrovaGeneTTFactorTufts UniversityTurnstone BiologicsTyme TechnologiesUltragenyx PharmaceuticalsUluruUnigene LaboratoriesUniQureUniversal CellsUniversity College DublinUniversity Health NetworkUniversity of AlbertaUniversity of CaliforniaUniversity of Central Florida Research FoundationUniversity of ColoradoUniversity of Florida Research FoundationUniversity of GenevaUniversity of LouisvilleUniversity of MissouriUniversity of Notre of DameUniversity of PennsylvaniaUniversity of TexasUniversity of VirginiaUniversity of Western SydneyUniversity of ZurichUOPUppsalagruppen MedicalUpstream Peripheral TechnologiesUroGen PharmaValeant PharmaceuticalsValiPharmaValnevaValor BiotherapeuticsVanderbilt UniversityVasomune TherapeuticsVaxentVBL TherapeuticsVeloxis PharmaceuticalsVeracyteVereniumVerity PharmaceuticalsVeroScienceVertex PharmaceuticalsVida ConceptsVifor PharmaViiV HealthcareVirbacViropharmaVistaGen TherapeuticsVividion TherapeuticsVivusVolitionRXVoronoiVoyager TherapeuticsVyera PharmaceuticalsVYNE TherapeuticsVyrix PharmaceuticalsWatson PharmaceuticalsWAVE Life SciencesWigen BiomedicineWisconsin Alumni Research FoundationWorld Class ExtractionsWPD PharmaceuticalsWUGENXbrane BioscienceXencorXlife SciencesXPhyto TherapeuticsXTL BiopharmaceuticalsXynomic PharmaceuticalsYale UniversityYeda Research and Development CompanyYeugnam UniversityYissum Research DevelopmentZAI LaboratoryZalicusZenitechZenith EpigeneticsZiopharm OncologyZogenixZS PharmaZymeworks

For more information about this report visit https://www.researchandmarkets.com/r/r3xtk4

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

 

View original content:https://www.prnewswire.com/news-releases/pharmaceutical-and-biotechnology-royalty-rates-report-2024-essential-benchmark-data-for-dealmakers—royalty-rates-deal-financials-contract-documents-royalty-rate-trends-302088073.html

SOURCE Research and Markets